NIGRO, Gerardo
 Distribuzione geografica
Continente #
EU - Europa 3.867
NA - Nord America 2.765
AS - Asia 538
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
OC - Oceania 2
Totale 7.185
Nazione #
US - Stati Uniti d'America 2.758
IE - Irlanda 1.342
FR - Francia 575
GB - Regno Unito 455
UA - Ucraina 386
DE - Germania 337
IT - Italia 316
CN - Cina 273
SG - Singapore 199
SE - Svezia 177
GR - Grecia 117
FI - Finlandia 108
TR - Turchia 50
BE - Belgio 17
CZ - Repubblica Ceca 13
CA - Canada 7
IN - India 6
JP - Giappone 6
EU - Europa 5
NL - Olanda 5
RU - Federazione Russa 5
BR - Brasile 3
ES - Italia 3
NO - Norvegia 3
PL - Polonia 3
CO - Colombia 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
KE - Kenya 1
KR - Corea 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
VN - Vietnam 1
Totale 7.185
Città #
Dublin 1.341
Jacksonville 657
Chandler 518
Princeton 192
Medford 156
Bremen 148
Roxbury 146
Singapore 123
Ann Arbor 88
Wilmington 82
Boardman 73
Beijing 66
San Mateo 63
Caserta 56
Cambridge 45
Des Moines 44
Woodbridge 44
Jinan 25
New York 25
Nanjing 22
Düsseldorf 20
Nanchang 19
Mountain View 18
Brussels 15
Naples 15
Norwalk 15
Houston 14
Brno 13
Hebei 12
Helsinki 12
Milan 12
Redwood City 12
Lanzhou 11
Shenyang 11
Zhengzhou 11
Marano Di Napoli 10
Napoli 10
Taizhou 10
Changsha 9
Tianjin 9
Guangzhou 8
Haikou 8
Hangzhou 8
Lappeenranta 8
Taiyuan 7
Auburn Hills 6
Ashburn 5
Bacoli 5
Ningbo 5
Rome 5
Spring City 5
Cerro Maggiore 4
Changchun 4
Florence 4
Lubbock 4
Philadelphia 4
Shanghai 4
Avellino 3
Gunzenhausen 3
Hanover 3
Jessheim 3
Los Angeles 3
Munich 3
Nocera Superiore 3
Pagani 3
Palermo 3
Pelago 3
Prato 3
Rostock 3
Seattle 3
Tappahannock 3
Venice 3
Acerra 2
Afragola 2
Atlanta 2
Bath 2
Brighton 2
Brookings 2
Cagliari 2
Castelfidardo 2
Columbus 2
Dearborn 2
Fairfield 2
Gragnano 2
Groningen 2
Grumo Nevano 2
Herk-de-stad 2
Kocaeli 2
London 2
Lyon 2
Marigliano 2
Mcallen 2
Mirandola 2
Ottawa 2
Padova 2
Phoenix 2
Pievepelago 2
Pozzuoli 2
Rockville 2
Shaoxing 2
Totale 4.367
Nome #
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 81
Cardiomyopathies associated with Muscular Dystrophies 77
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 72
Novel mutations in LMNA A/C gene and associated phenotypes 70
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti ai campi elettromagnetici ELF 70
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 69
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 68
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 66
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 65
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 65
A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: Micro-echocardiographic evaluation 65
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 64
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 64
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 64
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 64
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 63
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. 63
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 63
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 62
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 62
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 61
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 59
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 59
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 59
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 59
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 59
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 59
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 59
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 58
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 58
ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? 58
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 58
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 58
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 57
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments 57
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 57
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 56
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 56
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 56
Idiopathic left ventricular tachycardia: Evidence of a his bundle 'bystander' participation 55
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 54
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 54
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 54
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 53
Evaluation of Becker cardiomyopathy by Vest investigation 52
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 52
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 52
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 51
Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise 51
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 51
Advances in basic and clinical research in laminopathies. 51
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 50
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 50
Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation 49
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 49
Ischemic heart disease therapy in the elderly: Risk/benefit ratio 49
The QT dispersion in the risk stratification of sudden death in Becker patients 49
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 49
Diagnosis and Management of Atrial Fibrillation by Primary Care Physicians in Italy : A Retrospective, Observational Analysis. 49
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 48
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 47
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results 47
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 46
Arrhythmic risk in Steinert Disease 46
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti a campi elettromagnetici ELF. Atti del 64° Congresso Nazionale SIMLII 46
Management of cardiac involvement in muscular dystrophies: Paediatric versus adult forms 46
Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored) 46
Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review 45
Anaesthesia and Rare Neuromuscular Diseases 44
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 44
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience 44
P3.14 New AAVs for the muscle gene therapy in sarcoglycan deficient animals 44
Heart rate variability, obesity, and bariatric-induced weight loss: the importance of selection criteria 43
Cardiopulmonary resuscitation in pectus excavatum patients: is it time to say more? 43
Rischio aritmico nella Distrofia Miotonica tipo 1 (Studio RAMYD): Risultati preliminari ad un anno 42
Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study 42
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 41
Use of a lower dosage liver-Detargeted AAV vector to prevent hamster muscular dystrophy. 41
Role of electrophysiological evaluation for the best device choice to prevent sudden cardiac death in patients with Myotonic Dystrophy Type 1 and Emery Dreifuss Muscular Dystrophy 41
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 41
Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. 40
Cardiac involvement in laminopathies–short invited review 40
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 40
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study 39
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 39
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 39
Interazione tra campi elettromagnetici ELF e ritmo cardiaco in macchinisti di veicoli a trazione elettrica: ricerca di un indice predittivo di rischio aritmico 38
Evaluation of the effectiveness of the permanent biventricular pacing or implantable cardioverter-defibrillator in Becker patients with dilated cardiomyopathy and advanced heart failure 38
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 38
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients 37
ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. 37
Cardiomyopathies: diagnosis of types and stages 37
Monitoring of markers suitable for the prognosis of the cardiomyopathies in muscle dystrophies 37
Is Heart Rate Variability a prognostic indicator in patients with Dystrophia Myotonica type 1? 37
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence 37
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 37
Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications 37
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 37
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 37
DOES HIGH PERCENTAGE OF RIGHT VENTRICULAR PACING HAVE AN INFLUENCE ON PAROXYSMAL ATRIAL FIBRILLATION INCIDENCE IN MYOTONIC DYSTROPHY TYPE 1 PATIENTS? 36
Totale 5.148
Categoria #
all - tutte 33.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.214 251 179 105 29 113 51 190 48 131 43 51 23
2020/20211.107 86 4 97 90 235 11 148 101 15 121 160 39
2021/20221.336 68 26 52 48 403 4 10 36 44 192 96 357
2022/20232.289 223 43 24 175 264 160 5 110 1.197 21 37 30
2023/2024845 55 38 36 64 340 32 15 23 4 17 62 159
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 7.585